A leech therapy device adapted to latch a medicinal leech to a predetermined wound site is provided. The leech therapy device includes a conduit extending between a first end to a second end; an inner diameter of the conduit dimensioned to receive a medicinal leech, the inner diameter being less than twice a girth of the medicinal leech; and a cutout provided in the conduit closer to the first end than the second end; the cutout extending over a surface area between 100 and 150 squared millimeters. Wherein a user places a medicinal leech into the inner diameter, wherein a head of the medicinal leech is adjacent to the cutout, and then the user selectively positions said leech therapy device so that the cutout substantially circumscribed the wound site so that the medicinal leech can engage the wound site.

A system for attachment of a device to a bone is provided. The system includes an internal axial rod with a proximal and distal end that is configured to be inserted and secured into a bone cavity’s distal end. The system can also include an internal-external transfer rod with a proximal and distal end mounted into the distal end of the axial rod and a central channel extending through the transfer rod from the proximal end to the distal end and a plurality of attachment rings for attaching at least one tissue or muscle group to the transfer rod. The system also includes a bio-compatible and bio-occlusive artificial membranes (BIOCAMS) lamina, wherein the lamina includes either a polyetheretherketone (PEEK) mesh, a biocompatible polymer, a carbon fiber polymer, an artificial tissue polymer, molded donor tissue, allogenic tissue, a collagen/hyaluronic acid-based tissue, or connective tissue biosynthetic substrate material suitable as webbing.

The invention relates to a metallic, nanoporous canister used to encapsulate cellular and/or biotherapeutic agents. The device is biocompatible and functions to wholly isolate a therapeutically active agent and/or cells therein. Their implantation, and survival in vivo, permits the local or systemic diffusion of their encapsulated cellular and/or biomolecular and therapeutics factors with the potential to promote repair of damaged or degenerated tissues in mammalian hosts, primarily humans.

A fluid distribution system for delivering fluid internally of a body comprises a hollow needle and an implantable access port. The needle has a tip with a predetermined shape. The access port includes (a) a housing that includes at least two fluid outlets, (b) a septum received in the housing, and (c) a valve member rotatable in the housing. The valve member includes valve fluid inlet and outlet openings and a valve inlet passage extending from the inlet opening to the outlet opening. The valve inlet passage has a shape complementary to the shape of the needle tip. The valve member is rotatable into (i) a first position in which the valve fluid outlet opening communicates with a first housing fluid outlet and (ii) a second position in which the valve fluid outlet opening communicates with a second housing fluid outlet.

A method of preventing infections in vascular access devices in which an acoustic wave generator is attached to the vascular access catheter, and the acoustic wave generator is activated to produce acoustic waves, which are transmitted to the vascular access catheter to create mechanical vibrations in the vascular access catheter. The acoustic waves may be ultrasound waves. The acoustic wave generator may be attached to a catheter tube of the vascular access catheter or attached to a hub of the vascular access catheter. The acoustic wave generator a separate device that is removably clipped to the vascular access catheter, may be provided in a vascular access catheter stabilization device or may be integral with the vascular access catheter.

The present disclosure provides an apparatus for intracranial drug injection including a body unit having a through-hole extending between a first opening in a topmost surface and a second opening in a bottommost surface, a cap unit having a shape corresponding to at least a part of an inner surface of the through-hole and being inserted into the first opening to cover the first opening, and a tube unit having one end coupled to the second opening and another end extending toward an affected brain lesion.

An access port is disclosed for use in minimally invasive surgical procedures performed within a patient's abdominal cavity, which includes a body defining a bore configured to guide at least one surgical instrument into the abdominal cavity, and concave and convex anchoring regions for securing the access port relative to the abdominal cavity.

A vascular access site management system includes a stabilization body and a flow housing that is rotatable relative to the stabilization body. The flow housing may have a flow path extending through it to allow fluids to be introduced into or extracted from a patient via a catheter connected to the vascular access site management system. The vascular access site management system may also include a needle free connector fluidly connected to the flow housing via a section of tubing.

A vascular access device that prevents needle infiltration, provides a repeatable same-site access, and simplifies cannulation all while being minimally invasive and allows patients to self-cannulate.

Disclosed are a port and methods of implanting thereof minimally invasively in a body of a subject. A rear portion of the port comprises a port gripping portion configured for clamping by a clamping head of a medical clamp. The port can be pushed with the medical clamp through a surgical opening and a subcutaneous void and/or passage to a target implantation site, and, and the medical clamp can be released from the port gripping portion and removed the from the subcutaneous void and/or passage.